Neuraxis lowers warrant exercise price to $2.38; SPA not yet closed

Neuraxis, INC

Exercise price of all warrants reduced from $5.25 to $2.38 per share due to SPA with Flagstaff International.
SPA for Series B Preferred Stock at $2.38/share has not been paid or issued as of Dec 19, 2023.
New 2023 warrants for 609,760 shares and PA warrants for 144,990 shares not yet issued.
2022 warrant share count unchanged (793,655 shares); total warrants ~1.42M shares at new lower price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.